MOHW's inconsistent drug related policy triggers the mounting discontent

Published: 2002-06-12 07:00:00

Updated: 2002-06-12 07:00:00

Pharmaceutical industry sources say that the inconsistent drug-related policy of the Ministry of Health and Welfare (MOHW) has rekindled a severe opposition from the domestic pharmaceutical industry, over the MOHW's posture to acknowledge the original insurance price on some of import-switched pr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK